U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07401524) titled 'Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage' on Jan. 13.
Brief Summary: The goal of this clinical trial is to learn if the drug carbetocin works better than standard care to prevent heavy bleeding after childbirth in people carrying twin pregnancies. Heavy bleeding after delivery, also called postpartum hemorrhage, is more common after twin births and can lead to anemia, blood transfusions, and other serious health problems.
In this study, bleeding will be evaluated by measuring how much blood hemoglobin levels drop from before delivery to the day after delivery.
The main questions t...